Grith Hagel
Founder presso 2CUREX AB
Profilo
Grith Hagel is the founder of 2cureX ApS, where she holds the title of Head-Project Management since 2011.
She is also the founder of 2cureX AB, where she holds the title of Vice President-Innovation.
Ms. Hagel is also the founder of Noapab Holdings A..
Ms. Hagel's former jobs include being a Principal at Novo Nordisk A and Carlsberg A.
Posizioni attive di Grith Hagel
Società | Posizione | Inizio |
---|---|---|
2CUREX AB | Founder | 01/01/2006 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Founder | 07/04/2010 |
Precedenti posizioni note di Grith Hagel
Società | Posizione | Fine |
---|---|---|
CARLSBERG A/S | Corporate Officer/Principal | - |
Noapab Holdings A/S | Founder | - |
NOVO NORDISK A/S | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
NOVO NORDISK A/S | Health Technology |
CARLSBERG A/S | Consumer Non-Durables |
2CUREX AB | Health Technology |
Aziende private | 2 |
---|---|
Noapab Holdings A/S | Commercial Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Grith Hagel